Deutsche Bank Ag\ I Teos Therapeutics, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in I Teos Therapeutics, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 26,949 shares of ITOS stock, worth $207,237. This represents 0.0% of its overall portfolio holdings.

Number of Shares

26,949

Previous 21,041 28.08%

Holding current value

$207,237

Previous $312,000 11.86%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$10.09 - $17.97 $59,611 - $106,166	5,908 Added 28.08%	26,949 $275,000
Q2 2024 Aug 14, 2024	SELL	$10.33 - $18.09 $27,240 - $47,703	-2,637 Reduced 11.14%	21,041 $312,000
Q1 2024 May 15, 2024	BUY	$9.89 - $13.64 $3,847 - $5,305	389 Added 1.67%	23,678 $322,000
Q4 2023 Feb 14, 2024	SELL	$8.57 - $11.06 $11,500 - $14,842	-1,342 Reduced 5.45%	23,289 $255,000
Q3 2023 Nov 09, 2023	BUY	$10.95 - $14.6 $27,944 - $37,259	2,552 Added 11.56%	24,631 $269,000
Q2 2023 Aug 14, 2023	SELL	$12.93 - $18.05 $764,706 - $1.07 Million	-59,142 Reduced 72.82%	22,079 $292,000
Q1 2023 May 15, 2023	BUY	$13.02 - $22.62 $93,952 - $163,225	7,216 Added 9.75%	81,221 $1.11 Million
Q4 2022 Feb 13, 2023	BUY	$17.77 - $21.6 $1.02 Million - $1.24 Million	57,633 Added 352.02%	74,005 $1.45 Million
Q3 2022 Nov 14, 2022	SELL	$18.6 - $27.25 $10.9 Million - $15.9 Million	-583,459 Reduced 97.27%	16,372 $312,000
Q2 2022 Aug 11, 2022	SELL	$16.57 - $35.1 $1.37 Million - $2.91 Million	-82,971 Reduced 12.15%	599,831 $12.4 Million
Q1 2022 May 13, 2022	BUY	$31.92 - $47.45 $21.4 Million - $31.8 Million	670,533 Added 5465.26%	682,802 $22 Million
Q4 2021 Feb 11, 2022	SELL	$26.23 - $47.86 $1.52 Million - $2.77 Million	-57,898 Reduced 82.51%	12,269 $571,000
Q3 2021 Nov 04, 2021	SELL	$23.91 - $29.58 $9,970 - $12,334	-417 Reduced 0.59%	70,167 $1.9 Million
Q2 2021 Aug 11, 2021	SELL	$17.9 - $36.1 $18,669 - $37,652	-1,043 Reduced 1.46%	70,584 $1.81 Million
Q1 2021 May 13, 2021	BUY	$30.86 - $44.2 $1.96 Million - $2.81 Million	63,653 Added 798.26%	71,627 $0
Q4 2020 Feb 16, 2021	BUY	$21.59 - $33.95 $48,944 - $76,964	2,267 Added 39.72%	7,974 $270,000
Q3 2020 Nov 12, 2020	BUY	$17.57 - $32.92 $100,271 - $187,874	5,707 New	5,707 $141,000

Others Institutions Holding ITOS

# of Institutions

166

Shares Held

36.6M

Call Options Held

1.95M

Put Options Held

374K

View Full List

About iTeos Therapeutics, Inc.

Ticker ITOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,575,300
Market Cap $274M
Description
Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...

More about ITOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account